نتائج البحث 331-340 من 10438 لعملية البحث عن oral
... Oral and throat cancer, Laryngeal cancer, Salivary gland cancer, Skin lesion. إظهار المزيد من مجالات التخصص من أجل Kendall K. Tasche, M.D.. طلب تحديد موعد.
... (Oral Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition ...
D.M.D.. Oral and Maxillofacial Surgeon. Rochester, MN. مناطق التركيز: Joint replacement surgery, Scar revision, Trauma care, Total TMJ replacement, Minimally ...
... Oral and throat cancer, Laryngeal cancer, Salivary gland cancer, Oropharyngeal cancer, Radiation injury, Hypopharyngeal cancer. إظهار المزيد من مجالات التخصص ...
other non-hypermobile EDS subtypes and whether sex and/or age differences exist, and to determine whether serum biomarkers and comorbidities differ between ...
Oral cavity carcinoma, stages I to IV: Diagnosis to first treatment (adult). Mayo Clinic; 2017. Head and neck cancers. National Comprehensive Cancer Network ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
Rochester, Minn., Scottsdale/Phoenix, Ariz. The overall purpose is to study how a variety of technological approaches in Magnetic resonance imaging (MRI) can be ...
The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the genetic and ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.